Anti-NPT1/ SLC17A1/ NAPI-1 monoclonal antibody

Anti-NPT1/ SLC17A1/ NAPI-1 antibody for FACS & in-vivo assay

Target products collectionGo to SLC17A1/SLC17A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1548-Ab-1/ GM-Tg-hg-MP1548-Ab-2Anti-Human SLC17A1 monoclonal antibodyHuman
GM-Tg-rg-MP1548-Ab-1/ GM-Tg-rg-MP1548-Ab-2Anti-Rat SLC17A1 monoclonal antibodyRat
GM-Tg-mg-MP1548-Ab-1/ GM-Tg-mg-MP1548-Ab-2Anti-Mouse SLC17A1 monoclonal antibodyMouse
GM-Tg-cynog-MP1548-Ab-1/ GM-Tg-cynog-MP1548-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC17A1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1548-Ab-1/ GM-Tg-felg-MP1548-Ab-2Anti-Feline SLC17A1 monoclonal antibodyFeline
GM-Tg-cang-MP1548-Ab-1/ GM-Tg-cang-MP1548-Ab-2Anti-Canine SLC17A1 monoclonal antibodyCanine
GM-Tg-bovg-MP1548-Ab-1/ GM-Tg-bovg-MP1548-Ab-2Anti-Bovine SLC17A1 monoclonal antibodyBovine
GM-Tg-equg-MP1548-Ab-1/ GM-Tg-equg-MP1548-Ab-2Anti-Equine SLC17A1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1548-Ab-1/ GM-Tg-hg-MP1548-Ab-2; GM-Tg-rg-MP1548-Ab-1/ GM-Tg-rg-MP1548-Ab-2;
GM-Tg-mg-MP1548-Ab-1/ GM-Tg-mg-MP1548-Ab-2; GM-Tg-cynog-MP1548-Ab-1/ GM-Tg-cynog-MP1548-Ab-2;
GM-Tg-felg-MP1548-Ab-1/ GM-Tg-felg-MP1548-Ab-2; GM-Tg-cang-MP1548-Ab-1/ GM-Tg-cang-MP1548-Ab-2;
GM-Tg-bovg-MP1548-Ab-1/ GM-Tg-bovg-MP1548-Ab-2; GM-Tg-equg-MP1548-Ab-1/ GM-Tg-equg-MP1548-Ab-2
Products NameAnti-SLC17A1 monoclonal antibody
Formatmab
Target NameSLC17A1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC17A1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NPT1/ SLC17A1/ NAPI-1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm001852mouse Slc17a1 Lentivirus plasmid
    ORF Viral VectorvGMLPm001852mouse Slc17a1 Lentivirus particle


    Target information

    Target IDGM-MP1548
    Target NameSLC17A1
    Gene ID6568,20504,171080,694338,100683700,101096062,507535,100068069
    Gene Symbol and SynonymsNAPI-1,Napi1,NPT-1,NPT1,SLC17A1
    Uniprot AccessionQ14916,Q62795
    Uniprot Entry NameNPT1_HUMAN,NPT1_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000124568
    Target ClassificationN/A

    The target: SLC17A1, gene name: SLC17A1, also named as NAPI-1, NPT-1, NPT1. Predicted to enable sialic acid transmembrane transporter activity. Involved in urate metabolic process and urate transport. Located in apical plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.